Online inquiry

IVTScrip™ mRNA-Human ADRB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8968MR)

This product GTTS-WK8968MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADRB2 protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_000024.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 154
UniProt ID P07550
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADRB2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8968MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19724MR IVTScrip™ mRNA-Human ANKRD39, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD39
GTTS-WK25637MR IVTScrip™ mRNA-Human ARL16, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL16
GTTS-WK27741MR IVTScrip™ mRNA-Human ARL4A, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARL4A
GTTS-WK11930MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK23827MR IVTScrip™ mRNA-Human ARID5A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARID5A
GTTS-WK23844MR IVTScrip™ mRNA-Human ARL5A, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARL5A
GTTS-WK28607MR IVTScrip™ mRNA-Human ARHGEF10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF10
GTTS-WK22810MR IVTScrip™ mRNA-Human APIP, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APIP
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW